- Home
- KZIA vs BOF Comparison
KZIA vs BOF Comparison
Compare KZIA & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- BOF
- Stock Information
- Founded
- KZIA 1994
- BOF 2017
- Country
- KZIA Australia
- BOF United States
- Employees
- KZIA N/A
- BOF N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- BOF Packaged Foods
- Sector
- KZIA Health Care
- BOF Consumer Staples
- Exchange
- KZIA Nasdaq
- BOF Nasdaq
- Market Cap
- KZIA 12.6M
- BOF 12.5M
- IPO Year
- KZIA 1999
- BOF 2023
- Fundamental
- Price
- KZIA $4.90
- BOF $1.86
- Analyst Decision
- KZIA Strong Buy
- BOF
- Analyst Count
- KZIA 1
- BOF 0
- Target Price
- KZIA $20.00
- BOF N/A
- AVG Volume (30 Days)
- KZIA 148.4K
- BOF 694.1K
- Earning Date
- KZIA 11-19-2024
- BOF 11-19-2024
- Dividend Yield
- KZIA N/A
- BOF N/A
- EPS Growth
- KZIA N/A
- BOF N/A
- EPS
- KZIA N/A
- BOF N/A
- Revenue
- KZIA $382.00
- BOF $5,215,452.00
- Revenue This Year
- KZIA $4,053,954.00
- BOF N/A
- Revenue Next Year
- KZIA N/A
- BOF N/A
- P/E Ratio
- KZIA N/A
- BOF N/A
- Revenue Growth
- KZIA N/A
- BOF 703.78
- 52 Week Low
- KZIA $1.90
- BOF $0.61
- 52 Week High
- KZIA $15.80
- BOF $4.11
- Technical
- Relative Strength Index (RSI)
- KZIA 50.25
- BOF 60.04
- Support Level
- KZIA $5.21
- BOF $1.72
- Resistance Level
- KZIA $6.88
- BOF $2.20
- Average True Range (ATR)
- KZIA 0.76
- BOF 0.14
- MACD
- KZIA -0.11
- BOF 0.04
- Stochastic Oscillator
- KZIA 22.80
- BOF 66.18
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.